Skip to main content Skip to section navigation Skip to footer

Processa Pharmaceuticals, Inc.

  • Home
  • About
    • Overview
    • Partnering
    • Management Team
    • Product Development Team
    • Board of Directors
    • Medical & Scientific Advisory Board
  • Product Pipeline
    • Overview
    • PCS499
    • PCS12852
    • PCS3117
    • PCS6422
    • PCS11T
    • Publications
  • Our Clinical Trials
    • Overview
    • PCS499
    • PCS6422
  • News & Media
    • Press Releases
    • Presentations
    • Events
    • In The News
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Contact
  • Careers

Presentations

News & Media

News & Media

  • Press Releases
  • Presentations
  • Events
  • In The News
Corporate Update Presentation
Aug 12, 2022

Corporate Update Presentation

Clinical Pipeline Update
May 12, 2022

Clinical Pipeline Update

Clinical Pipeline Update
Mar 30, 2022

Clinical Pipeline Update

Clinical Pipeline Update
Mar 17, 2022

Clinical Pipeline Update

Clinical Pipeline Update
Nov 12, 2021

Clinical Pipeline Update

Corporate Overview September 2021
Sep 1, 2021

Corporate Overview September 2021

Clinical Pipeline Update
Mar 25, 2021

Clinical Pipeline Update

Corporate Presentation
Jan 11, 2021

Corporate Presentation

Clinical Pipeline Update
Nov 12, 2020

Clinical Pipeline Update

Corporate Presentation
May 28, 2020

Corporate Presentation

RSS
  • 1
  • 2
  • Next
Twitter LinkedIn
©2022 Processa Pharmaceuticals, Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap Manage Cookie Preferences